“…Previously, the term CSX was used to refer to patients with no obstructive CAD but did not require proof of ischemia23, 24 and also included patients with acute coronary syndromes and no obstructive CAD 22, 23, 25. Advanced evaluation can now identify CMD or macrovascular dysfunction by invasive or noninvasive measurements of CFR in a majority of these patients,12, 26 while coronary atherosclerosis and better characterization of plaques can be assessed by intravascular ultrasound, optical coherence tomography, or computed coronary tomography angiography when not evident or appreciated at invasive coronary angiography 27, 28, 29.…”